{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:01Z","timestamp":1786119661552,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/mph.0b013e3181e9038d","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T06:05:07Z","timestamp":1285913107000},"page":"594-600","source":"Crossref","is-referenced-by-count":29,"title":["A Trial to Assess the Efficacy of Glutamic Acid in Prevention of Vincristine-induced Neurotoxicity in Pediatric Malignancies: A Pilot Study"],"prefix":"10.1097","volume":"32","author":[{"given":"Galila M.","family":"Mokhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa Y.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Samir","family":"Elbarbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210227","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/01658100590959859","article-title":"Unilateral palpebral ptosis associated with vinblastine therapy","volume":"29","author":"Parentin","year":"2005","journal-title":"Neuro-Ophthalmology"},{"key":"R2-5-20210227","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pbc.21435","article-title":"Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients","volume":"50","author":"Renbarger","year":"2008","journal-title":"Pediatric Blood and Cancer"},{"key":"R3-5-20210227","first-page":"122","article-title":"Severe peripheral neuropathy secondary to vincristine therapy","volume":"20","author":"Oytun","year":"2007","journal-title":"Marmara Med J"},{"key":"R4-5-20210227","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","article-title":"Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"25","author":"Chauvenet","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-5-20210227","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1745-6215-8-25","article-title":"Randomised trial of glutamine and selenium supplemented parenteral nutrition for critically ill patients. Protocol version 9, 19 February 2007, known as SIGNET (Scottish Intensive Care Glutamine or Selenium Evaluative Trial)","volume":"8","author":"Andrews","year":"2007","journal-title":"Trials"},{"key":"R6-5-20210227","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tvjl.2005.11.007","article-title":"The role of glutamate in central nervous system health and disease, The Animal Health Trust, Centre for Small Animal Studies","volume":"173","author":"Platt","year":"2007","journal-title":"Vet J"},{"key":"R7-5-20210227","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0253-7613.16210","article-title":"L-Glutamic acid and glutamine: exciting molecules of clinical Interest","volume":"37","author":"Kulkarni","year":"2005","journal-title":"Indian J Pharmacol"},{"key":"R8-5-20210227","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00280-008-0689-7","article-title":"Interleukin-6 protects against Paclitaxel, cisplatin and vincristine-induced neuropathies without impairing Chemotherapeutic activity","volume":"62","author":"Callizot","year":"2008","journal-title":"Cancer Chemotherapy Pharmacol"},{"key":"R9-5-20210227","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0006-2952(75)90185-9","article-title":"Uptake and binding of vincristine by murine leukemia cells","volume":"24","author":"Bleyer","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"R10-5-20210227","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0002-9343(88)90306-3","article-title":"Amelioration of vincristine neurotoxicity by glutamic acid","volume":"48","author":"Jackson","year":"1988","journal-title":"Am J Med"},{"key":"R11-5-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07558.x","article-title":"Therapy of chemotherapy-induced peripheral neuropathy","volume":"145","author":"Kaley Thomas","year":"2009","journal-title":"British J Haematol"},{"key":"R12-5-20210227","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/WCO.0b013e3282f1a06e","article-title":"Neurologic complications of chemotherapy agents","volume":"20","author":"Kannarkat","year":"2007","journal-title":"Current Opinion in Neurol"},{"key":"R13-5-20210227","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00280-008-0876-6","article-title":"Central and peripheral nervous system toxicity of common chemotherapeutic agents","volume":"63","author":"Chrissa","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"R14-5-20210227","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/08880010701451327","article-title":"Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy","volume":"24","author":"Ozyurek","year":"2007","journal-title":"Pediatric Hematol Oncol"},{"key":"R15-5-20210227","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00134-007-0547-9","article-title":"Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy","volume":"33","author":"Berg","year":"2007","journal-title":"Intensive Care Med"},{"key":"R16-5-20210227","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0006-2952(71)90286-3","article-title":"Colchicine, vinblastine and griseofulvin: pharmacological studies with human leukocytes","volume":"20","author":"Creasy","year":"1971","journal-title":"Biochem Pharmacol"},{"key":"R17-5-20210227","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00253273","article-title":"Improved tolerance of Vincristine by glutamic acid","volume":"2","author":"Jackson","year":"1984","journal-title":"J Neuro-Oncology"},{"key":"R18-5-20210227","first-page":"49","article-title":"Hodgkin's disease, carcinoma of the breast, and other tumors treated with vinblastine sulfate","volume":"18","author":"Armstrong","year":"1962","journal-title":"Cancer Chemother Rep"},{"key":"R19-5-20210227","first-page":"1192","article-title":"Reduction of paclitaxel-induced peripheral neuropathy with glutamine","volume":"7","author":"Vahdat","year":"2001","journal-title":"Clinical Cancer Res"},{"key":"R20-5-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.clon.2004.11.014","article-title":"Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and Electrophysiologic Study","volume":"17","author":"Stubblefield","year":"2005","journal-title":"Clin Oncol (Royal College of Radiologists)"},{"key":"R21-5-20210227","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1634\/theoncologist.12-3-312","article-title":"Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients","volume":"12","author":"Wang","year":"2007","journal-title":"Oncologist"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181e9038d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:41:38Z","timestamp":1786041698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201011000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181e9038d","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}